Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population

অনুরূপ উপাদানগুলি

• Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
  অনুযায়ী: Cameron, Jodi, অন্যান্য
  প্রকাশিত: (2014)
• Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
  অনুযায়ী: Forgie, Jennifer, অন্যান্য
  প্রকাশিত: (2014)
• The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
  অনুযায়ী: MacRae, Megan, অন্যান্য
  প্রকাশিত: (2014)
• Use of Omalizumab to treat a nine-year old, with steroid-dependent, allergic asthma, adrenal insufficiency and vertebral compression fractures due to steroid induced severe osteoporosis
  অনুযায়ী: Ring, Alicia, অন্যান্য
  প্রকাশিত: (2011)
• Treatment of moderate to severe pediatric asthma Omalizumab and potential future use of monoclonal antibodies
  অনুযায়ী: Wright, Lakiea S., অন্যান্য
  প্রকাশিত: (2016)